3Bjom Blomberg, Sergio Spinaei, Bernard Fourie, et al. The rationale for recommending fixed - dose combination tablets for treatment of tu- berculosis [ J] . BulletinoftheWorld Health Organization, 2001, 79 (1): 61-68.
4Yee D, Valiquette C, Pelletier M, et al. Incidence of serious side effects from first - line antitubereulosis drogs among patients treated for active tuberculosis [ J] . American Journal of Respiratory and Critical Care Medicine, 2003, 167 (11): 1472-1 477.